Queen's Birthday Honour for Professor Georgina Long

Queen's Birthday Honour for Professor Georgina Long

8 June 2020

Congratulations to Melanoma Institute Australia Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List announced today by the Governor-General.

Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for  distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies. 

‘This is well deserved recognition of Professor Long’s lifesaving work and ground-breaking research,’ said fellow MIA Co-Medical Director, Professor Richard Scolyer. ‘She has changed the face of melanoma treatment around the world and many thousands of people are alive today thanks to her intellect, determination and passion.

‘It is due to her research and thought leadership globally that the world is now realistically looking towards a day with zero deaths from melanoma,’ he added.

Professor Long is one of the world’s most renowned melanoma clinicians and researchers with her clinical trials tripling life expectancy for some advanced melanoma patients and essentially curing others.

She leads the clinical trials team at MIA, with a focus on targeted therapy and immune-oncology in melanoma, and is Principal Investigator on Phase I, II and III trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases.

Professor Long is a fierce advocate that recent advances and breakthroughs in melanoma treatment stem from the collective effort of the dedicated multi-disciplinary team at MIA that she co-leads with her colleague and friend Professor Scolyer.

In a double world first, she is the first woman and the first Australian to be President of the prestigious US-based Society for Melanoma Research (SMR). She has authored over 300 publications in melanoma clinical and translational research, including in the world’s leading scientific high-impact journals such as the New England Journal of Medicine and The Lancet, and has presented at hundreds of international conferences.

Professor Long’s Queen’s Birthday Honour follows numerous awards including being named the 2018 Outstanding Researcher of the Year at the NSW Premiers Awards for Outstanding Cancer Research and receiving the prestigious Research Australia, GSK Research Excellence Award in 2018 and the Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research in 2016.

‘Professor Long’s recognition in the Queen’s Birthday Honours List is a proud day for all of us here at Melanoma Institute Australia,’ said CEO Matthew Browne.

‘Not only is she saving lives and changing the future for melanoma patients around the world, but she is also an inspiring role model for all young Australians, particularly women, who may be working towards a career in science and medicine,’ he said.

 

Support PBS listing for pembrolizumab
23 Aug 2018

Support PBS listing for pembrolizumab

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.

World Congress on Cancers of the Skin 2018
17 Aug 2018

World Congress on Cancers of the Skin 2018

The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.

Melanoma Institute Australia welcomes new CEO Matthew Browne
09 Aug 2018

Melanoma Institute Australia welcomes new CEO Matthew Browne

Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).

Melanoma in Practice: Nurse Conference
26 Jul 2018

Melanoma in Practice: Nurse Conference

It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’. 

Reducing the risk of melanoma in young adults
19 Jul 2018

Reducing the risk of melanoma in young adults

A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.

Melanoma Institute Australia launches free e-learning education portal
20 Jun 2018

Melanoma Institute Australia launches free e-learning education portal

Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.

David Day and a lifetime of missed moments
08 Jun 2018

David Day and a lifetime of missed moments

When David lost his life last year, he was 33, with three daughters under six.

Australian melanoma experts share latest breakthroughs with world's best oncologists
06 Jun 2018

Australian melanoma experts share latest breakthroughs with world's best oncologists

ASCO 2018 brings together the world's best in oncology from around the world. 

ASCO 2018 – the important role of clinical trials
06 Jun 2018

ASCO 2018 – the important role of clinical trials

Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.

MIA Scoops Awards at the International Academy of Pathology
04 Jun 2018

MIA Scoops Awards at the International Academy of Pathology

Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology. 

Updated Clinical Guidelines for Melanoma
25 May 2018

Updated Clinical Guidelines for Melanoma

Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.

Melanoma and Marital Status: A Study
11 May 2018

Melanoma and Marital Status: A Study

An American study has discovered a link between early detection and marital status in melanoma diagnosis. 

A weekend in Paris talking all things pathology...
02 May 2018

A weekend in Paris talking all things pathology...

An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.

Our own 'Australian Story'
30 Apr 2018

Our own 'Australian Story'

Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts. 

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
27 Apr 2018

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma

For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.

The inspiring story of Emma Betts premieres on Australian Story
16 Apr 2018

The inspiring story of Emma Betts premieres on Australian Story

'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma. 

Toyota helps tackle Australia's national cancer - melanoma
09 Apr 2018

Toyota helps tackle Australia's national cancer - melanoma

Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.

Tackling the Kokoda Trail for melanoma
06 Apr 2018

Tackling the Kokoda Trail for melanoma

Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.

Professor Richard Scolyer presents at world's largest annual meeting of pathologists
29 Mar 2018

Professor Richard Scolyer presents at world's largest annual meeting of pathologists

Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.

Congratulations to Kaye Oakley
29 Mar 2018

Congratulations to Kaye Oakley

A round of applause for a well deserved win.